Overview Fundamentals API Earnings EOD API Sample Code Pricing

Nutriband Inc (NTRB NASDAQ) stock market data APIs

$8.67 1.11(14.7%) as of July 26, 2024
Price chart is built with Anychart

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Nutriband Inc Financial Data Overview

7.56
8.67
-
8.67
7.55
1.53-9.595
94 070 K
11 106 K
2 017 K
-0.2072
0.49
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NTRB',
Type: 'Common Stock',
Name: 'Nutriband Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00GSMQF58',
ISIN: NULL,
CUSIP: NULL,
CIK: '1676047',
EmployerIdNumber: NULL,
FiscalYearEnd: 'January',
IPODate: '2017-11-30',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Nutriband Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 017 K
  • EBITDA -5 461 903
  • Earnings Per Share -0.77
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Nutriband Inc Earnings via APIs

  • Latest Release 2024-05-01
  • EPS/Forecast NaN

Get Nutriband Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com